LYMPHOMA
Clinical trials for LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA trials appear
Sign up with your email to follow new studies for LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted attack on cancer cells during transplant shows promise
Disease control TerminatedThis study tested whether adding a targeted drug called inotuzumab ozogamicin to a stem cell transplant regimen could better control leukemia and lymphoma. The drug is designed to seek out and kill cancer cells that have a specific marker (CD22). Researchers enrolled 15 patients …
Matched conditions: LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Experimental drug aims to mop up remaining cancer cells after standard treatment
Disease control TerminatedThis study tested whether the drug ofatumumab could control chronic lymphocytic leukemia or small lymphocytic lymphoma that remained after patients completed chemotherapy. Participants received up to 20 infusions over two years to target residual cancer cells. The trial was termi…
Matched conditions: LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New drug combo tested to control blood cancers in First-Time patients
Disease control TerminatedThis study tested a two-drug combination as the first treatment for people newly diagnosed with certain slow-growing blood cancers called follicular lymphoma or marginal zone lymphoma. The goal was to see if adding the experimental drug umbralisib to the approved drug rituximab c…
Matched conditions: LYMPHOMA
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New drug duo tested in fight against tough lymphomas
Disease control TerminatedThis study tested the safety and early signs of effectiveness of a two-drug combination (isatuximab plus cemiplimab) for people with certain lymphomas that had returned or stopped responding to prior treatments. It involved 58 participants with Hodgkin's lymphoma, diffuse large B…
Matched conditions: LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Targeted immunotherapy tested for Tough-to-Treat lymphoma
Disease control TerminatedThis study tested whether the immunotherapy drug pembrolizumab could help adults with a specific type of aggressive lymphoma that had returned or not responded to prior treatments. It focused on patients whose lymphoma cells had a particular genetic change (PD-L1 alteration). The…
Matched conditions: LYMPHOMA
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
High-Tech surgery aims to pinpoint hidden cancer clues
Diagnosis TerminatedThis study tested whether using real-time imaging during surgery could help doctors more accurately find and biopsy abnormal lymph nodes deep in the abdomen. The goal was to make these diagnostic surgeries safer, with less tissue damage and fewer complications. The trial was term…
Matched conditions: LYMPHOMA
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Diagnosis
Last updated Mar 30, 2026 14:29 UTC
-
Food fight against superbug: simple diet change may shield vulnerable cancer patients
Prevention TerminatedThis study tested whether a simple diet change—eating more fiber and less fat—could prevent C. difficile infections from coming back in cancer patients. It focused on people with leukemia or lymphoma who had just had their first or second C. diff infection. The trial was small an…
Matched conditions: LYMPHOMA
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Prevention
Last updated Mar 18, 2026 14:40 UTC
-
Can a simple rehab program bring back taste for cancer survivors?
Symptom relief TerminatedThis study tested a special training program designed to help people who have lost their sense of taste or smell after chemotherapy for blood cancers. It aimed to see if this 'sensory rehab' could improve their ability to taste and smell, which would help them eat better and feel…
Matched conditions: LYMPHOMA
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated Mar 20, 2026 14:47 UTC
-
Could your Phone's lock screen help cancer Survivors' hearts?
Symptom relief TerminatedThis study tested whether a special app on an Android phone could help cancer survivors become more physically active and improve their heart and blood vessel health. Participants were asked to use the app and wear a Fitbit for 3 months, with follow-up checks at 3 and 6 months. T…
Matched conditions: LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Penn State University • Aim: Symptom relief
Last updated Mar 11, 2026 14:54 UTC
-
Researchers launch registry to track challenges faced by young cancer survivors
Knowledge-focused TerminatedThis study created a registry to learn about the long-term health and wellbeing of young adults who survived cancer. It aimed to measure their levels of anxiety, depression, social support, and financial stress over time. Participants completed online surveys every 6-12 months to…
Matched conditions: LYMPHOMA
Sponsor: Young Adult Survivors United • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC